UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Dont Let Tax Savings Dictate Retirement Moves Hidden Costs of NoIncomeTax States Manchester University Mandates Work Placements for All Undergraduates in SectorFirst Initiative Japan Hotel Rates Hit Record as Western Tourists Fill Gap Left by Chinese Visitors Oil Prices Surge as US Military Strikes on Iran Stoke Supply Concerns Indian Market Ends Week on Positive Note LowPriced Stocks Draw Attention Elevance Health Q1 2026 Earnings EPS Beats Estimates by 151 Shares Edge Higher HNVR Q1 2026 Earnings Slight EPS Miss Amid Challenging Operating Environment FIS Q1 2026 Earnings EPS Surpasses Estimates Stock Slightly Lower AVBH Q1 2026 Earnings EPS Tops Estimates Amid Solid Core Banking Performance REXR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Energy Services of America Corporation ESOA Q1 2026 Earnings Profit Surges Past Expectations But Revenue Details Remain Unclear Euro Tech Holdings CLWT Surges 147 as Speculative Interest Builds Yext Inc YEXT Slips 22 as Stock Tests Key Support at 366 NAPCO Security Technologies NSSC Climbs 196 as Bullish Momentum Builds Artelo Biosciences ARTL Gains 735 Biotech Stock Tests Resistance Near 153 Gabelli MultiMedia Trust GGT Holds Steady at 427 Amid Quiet Trading UK Police Chiefs Call for Blocking Unsafe Social Media for Under16s B Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Gold Price Tailwinds Oxford Lane Capital Preferred OXLCO Edges Higher Approaches Key Resistance Zone BLSH Q1 2026 Earnings EPS Misses Estimates Stock Declines 217 ELME Q4 2025 Earnings Massive EPS Miss as Company Faces Headwinds Columbia Sportswear COLM Q1 2026 Earnings Massive EPS Surprise Powers Stock Rally AMBR Q4 2025 Earnings EPS Misses Estimates by Narrow Margin Shares Decline EDUC Q1 2026 Earnings Narrowing Loss Highlights Ongoing Restructuring CCAP Q1 2026 Earnings Narrow EPS Miss Highlights Steady Portfolio Returns Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones